Previous Page  13 / 38 Next Page
Information
Show Menu
Previous Page 13 / 38 Next Page
Page Background

Volume 5, Issue 2 (Suppl)

J Tradi Med Clin Natur

ISSN: JTMCN, an open access journal

Page 36

Notes:

Traditional Medicine 2016

September 14-16, 2016

conferenceseries

.com

September 14-16, 2016 Amsterdam, Netherlands

6

th

International Conference and Exhibition on

Traditional & Alternative Medicine

Decreased interleukin-4 (IL-4), IL-10 and IgE level of type I hypersensitive mice using scopoloetin isolated

from noni fruit (

Morinda citrifolia

L)

Yufri Aldi, Elliza Nasrul, Yanwirasti, Dian Handayani

and

Dachriyanus

Fakultas Farmasi, Indonesia

A

n

in vivo

study of the activity of scopoletin isolated from noni fruit (

Morinda citrifolia

L.) on the level of interleukin-4 (IL-4),

IL-10 and IgE in type I hypersensitive male Swiss-Webster mice has been carried out. Scopoletin was isolated from dried noni

powder by soxhletation method using dichloromethane, separated by column chromatography using silica gel as stationary phase

and n-hexane-ethyl acetate (1:4) as mobile phase, then purified by column chromatography using Sephadex LH20 as stationary

phase and methanol as mobile phase. Type I hypersensitive male mice were obtained by ovalbumin sensitization. Animal model were

divided into 5 groups: negative control group, positive control group, and scopoletin-treated group (1; 3; and 10 mg/kg). The results

showed that scopoletin at doses of 1, 3 and 10 mg/kg decreased the level of IL-4 of type I hypersensitive mice significantly (p<0.01).

The scopoletin at the dose of 10 mg/kg decreased the serum level of IL-4, IL-10, and IgE (P<0.01) to the normal level. The ability of

scopoletin to decrease IL-4 and IgE concentration of type I hypersensitive mice to its normal state was shown by dose of 10 mg/kg BW

(p>0.05), while for IL-10 concentration, the decrease until its normal level was shown by dose of 3 mg/kg BW (p<0.05).

Biography

Yufri Aldi is a Lecturer at the Faculty of Pharmacy, University of Andalas. He completed his PhD in 2013 at Andalas University. His research is in the field of

Farmaco-Immunology.

yufrialdi@gmail.com

Yufri Aldi et al., J Tradi Med Clin Natur 2016, 5:2 (Suppl)

http://dx.doi.org/10.4172/2167-1206.C1.002